Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Revenue

Repare Therapeutics had revenue of $11.62M in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $11.87M, down -82.16% year-over-year. In the year 2024, Repare Therapeutics had annual revenue of $53.48M with 4.58% growth.

• Revenue (ttm): $11.87M
• Revenue Growth: -82.16%
• P/S Ratio: 9.54
• Revenue / Employee: $92,016
• Employees: 129
• Market Cap: 114.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	53.48M	2.34M	4.58%
Dec 31, 2023	51.13M	-80.70M	-61.21%
Dec 31, 2022	131.83M	124.23M	1,634.61%
Dec 31, 2021	7.60M	7.47M	5,529.63%
Dec 31, 2020	135.00K	-	-